Kylin Therapeutics Inc — Form D
Kylin Therapeutics Inc of West Lafayette, IN, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-23. The offering totals $2.0M, of which $58K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-11-23
- Form: D
- Accession: 0001178858-09-000023
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $58K
- Remaining: $1.9M
- Minimum investment: $100K
- Investors: 2
- Date of first sale: 2009-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-111031
Issuer
- Name: Kylin Therapeutics Inc
- CIK: 0001418644
- Entity type: Corporation
- Jurisdiction: INDIANA
- Incorporated: 2006
- Address: 3000 Kent Avenue, West Lafayette, IN, 47906
- Phone: (765) 412-6661
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| J. Eric Davis | Director | West Lafayette, IN |
| Christopher Eric Meldrum | Director | West Lafayette, IN |
| Homer Eric Pearce | Director | West Lafayette, IN |
| J. Eric Davis | Executive Officer | West Lafayette, IN |
| Christopher Eric Meldrum | Executive Officer | West Lafayette, IN |
| Joseph Eric Trebley | Executive Officer | West Lafayette, IN |
More